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ABSTRACT--- 
Introduction: The study of processes and functional regulation in body under the changed (including the lower) body 
temperature is the important medical problem. Increase of body resistance to low environmental temperature is 
especially important for the patient reanimation after the cold exposure, and the assessment of mechanisms creating 
the tissue oxygen flux may help the development of ways for reanimation of a cooled body. 
Aim: Study effect of N-nitro-L-arginine methyl ester, L-arginine, or sodium nitroprusside  on the blood oxygen 
transport and the prooxidant-antioxidant balance during hypothermia and rewarming in rats. 
Methods: Cold exposure was performed in male rats  (body  weight 200-250 g,  n = 54) for 120 min under the box 
water temperature of 19°C; rewarming took the next 120 min, with a mean rate of 0.06°C/min. N-nitro-L-arginine 
methyl ester, L-arginine, or sodium nitroprusside  were administered intravenously during the second 60 min of 
hypothermia in 1 mL of saline. Hemoglobin-oxygen affinity was evaluated by p50 (blood pO2 at its 50% O2 saturation) 
determined by the ”mixing” method at 37C, pH 7.4 and pCO2 40 mm Hg and  at actual pH, pCO2 and temperature. 
We were analyzed the antioxidant protection (catalase activity, -tocopherol) and lipid peroxidation (conjugated 
diene, Schiff bases). 
Results: Infusion of L-arginine promoted the higher cold resistance and oxyhemoglobin dissociation curve shift 
rightwards, thereby reducing the hypoxic signs. It enhanced the antioxidant defense and reduced the levels of lipid 
peroxidation products, thereby providing the least prooxidant-antioxidant disbalance during the rewarming. However, 
other modifiers of L-arginine-NO pathway (N-nitro-L-arginine methyl ester, sodium nitroprusside) had not such 
effect. 
Conclusion: The L-arginine effect mediated by hemoglobin-oxygen affinity change may be used for the correction of 
metabolic disorders and improvement of body resistance to low environmental temperature. 
Keywords— hypothermia, rewarming, hemoglobin-oxygen affinity, nitric oxide 
_________________________________________________________________________________ 
 
1. INTRODUCTION 
The estimation of mechanisms influencing the oxygen flux to tissues is important for the investigations of hypothermia 
and ways to correct it. Many factors are known to contribute into the hypoxia induced by hypothermia: decrease of 
pulmonary ventilation, fall of minute blood volume, dramatic shift of the oxyhemoglobin dissociation curve (ODC) 
leftwards etc. By other hand, hypothermia results in the considerable decrease of tissue energetic needs and therefore in 
lower oxygen (O2) consumption 
1, 2, 18. The pathogenesis of rewarming is less studied, and many aspects of its 
development are unknown. 
Reactive free radicals are constantly generated in body. The antioxidant system reduce their concentrations and effects 
thereby forming the prooxidant-antioxidant balance 8. Low body temperature is associated with enhanced generation of 
reactive oxygen metabolites. This prooxidant shift results from the change in cellular metabolism, with a higher oxygen 
fraction utilized by oxygenases vs. oxidases (3). Cold stress disrupt the balance in an prooxidant-antioxidant system and 
cause oxidative damage to several tissues by altering the enzymatic and non-enzymatic antioxidant status, protein 
oxidation and lipid peroxidation (LPO) 10, 21. The blood oxygen-binding properties determine the conditions of oxygen 
diffusion to tissues and the values of tissue oxygen pressure 22 and take a specific part in the complex system of 
antioxidant defense 29. The preliminary shift of ODC leftwards during the hypothermia is accompanied by a shift of Ре
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prooxidant-antioxidant balance towards activation of the LPO, and the ODC shift rightwards is accompanied by the LPO 
lowering.  
Recently, the nitric oxide (NO) and hemoglobin (Hb) interaction has been actively studied. Hb has evolved to shuttle a 
triad of gases that are key to life: NO, CO2, and O2 
5. Three main NO derivatives of Hb have been known: 
nitrosylhemoglobin, nitrosohemoglobin (SNO-Hb) and methemoglobin. In the nitrosylhemoglobin molecule, NO is 
related to heme Fe2+ sites, whereas SNO-Hb is the result of the interaction of NO with cysteine (93) on the -globine 
chain 12, 26. The presence of different Hb compounds with NO can affect the hemoglobin-oxygen affinity (HOA) in the 
whole blood in different ways. Methemoglobin and SNO-Hb increase it, whereas nitrosylhemoglobin decreases. During 
the hypothermia, a modification of the L-arginine-NO pathway, an enhanced cold resistance, attenuated oxygen 
deficiency and a weaker ODC shift leftwards were observed only after the administration of L-arginine (the actual P50 
decreased by approximately 15 mm Hg and was significantly higher than in control) 28.   
The aim of this study was to investigate the blood oxygen transport and the prooxidant-antioxidant balance in rats 
during a modification of L-arginine-NO pathway combined with hypothermia and the following rewarming. 
 
2.  MATERIALS AND METHODS 
Male rats (body weight 200-250 g,  n = 54) were anesthetized by sodium thiopental (50 mg/kg intraperitoneally). 
During the hypothermia and rewarming the rats were placed into the special boxes without a direct contact with water. 
Fall and rise of rat body temperature were achieved by the 120-min hypothermia and 120-min rewarming, respectively, 
with a mean rate of 0.06°C/min.  
The following   L-arginine-NO   pathway   modifiers   were   used: N-nitro-L-arginine methyl ester (L-NAME), L-
arginine, or sodium nitroprusside (SNP). These substances were administered intravenously during the second 60 min of 
hypothermia in 1 mL of saline. Rats were subdivided into 6 groups: 1 – control (n=8); 2 – hypothermia (n=8); 3 – 
hypothermia/rewarming (n=11); 4 - administration of SNP (50 g/kg) and hypothermia/rewarming (n=9); 5 - 
administration of L-NAME (40 mg/kg) and hypothermia/rewarming (n=10); 6 - administration of L-arginine (300 mg/kg) 
and hypothermia/rewarming (n=8). Control, hypothermia, and hypothermia/rewarming groups received 1 mL of saline. 
Body temperature was measured every 10 min with electric thermometer. Blood samples were taken from right atrium, 
and then the tissue sampling was performed (lungs, liver, kidneys, heart). All surgical interventions were performed 
under the adequate analgesia. Experiments using the laboratory animals were approved by of University Ethical 
Committee on Animal Experiments. During the experimental procedure we followed University guide for the care and 
use of laboratory animals. 
PO2, O2 blood saturation (SO2) and acid-base balance (pH, venous carbon dioxide pressure (PCO2), concentration of 
bicarbonate (HCO3
-), the concentration of total carbon dioxide (TСО2), the actual excess of buffer bases (ABE), the  
standard excess of buffer bases (SBE) and the standard bicarbonate (SBC)) were measured with micro gas analyzer 
«Synthesis-15» (Instrumentation Laboratory) at 37С with the following correction to actual temperature value. HOA 
was assessed as P50 (blood PO2 under its 50% saturation by O2) as determined by a 'mixing method' 
23 at 37°C, pH 7.4 
and PCO2 = 40 mm Hg (P50stand). The values of P50 at actual pH, PCO2 and temperature (P50act) were calculated from 
P50stand by Severinghaus' equations (24) using the temperature coefficient lgP50/T = 0.024; the ODCs were 
calculated according to Hill's equation with n = 2.8 from the measured P50. The amounts of Hb were determined 
spectrophotometrically. Nitrate/nitrite was determined using the Griess reagent 15. 
Conjugated diene (CD) content was determined by UV absorption at 232-234 nm (indicating the conjugated double 
bonds of lipid hydroperoxides) 20. The results were expressed in relative units of optical density in 1 ml (A233/ml). The 
level of Schiff bases (SB) was determined by fluorescence intensity of chloroform extracts at excitation and emission 
wavelengths of 344 and 440 nm, respectively, with an F-4010 spectrofluorimeter (Hitachi). The results were expressed in 
relative units of intensity in 1 ml of plasma or red blood cells (RBCs) 4. 
Antioxidant system: catalase activity was determined by measurement of the rate of decomposition of hydrogen 
peroxide capable to generate a stable coloured complex with molybdenum salts which was measured with an SF-46 
spectrophotometer at 410 nm 4, -tocopherol (α-T) concentration was evaluated by fluorescence intensity of heptane 
extraction at excitation and emission wavelengths of 292 and 325 nm with an F-4010 spectrofluorimeter (Hitachi) using 
-tocopherol (Sigma Chemical Co., St. Louis) as reference 20. Protein content was measured according to Layne 14. 
The results obtained were analyzed statistically using Statistica 8 suite. Data are expressed as mean (M)±standard error 
mean (SEM). Normal distribution of data was assessed by the Kolmogorov-Smirnov test, Shapiro-Wilk’s W test. Since 
the data were not normally distributed, Mann-Whitney U tests for unrelated results were used to compare differences 
between the groups. A p value of <0.05 was accepted as statistically significant. Ре
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3. RESULTS 
In rats received 0.9% NaCl, the rectal temperature at the end of cooling was 28.5±0.20С (Figure 1). The least decrease 
of rectal temperature was noted after injection of L-arginine (29.1±0.10С, P0.05). SNP injection resulted in the lowest 
rectal temperature (27.1±0.20С, P0.01). In others groups of rats the rectal temperatures were not significantly different 
from control. At the end of rewarming the control rectal temperature was 35.4±0.10С (Figure 1).  The highest rectal 
temperatures at that time were observed in animals received SNP (35.8±0.10С, P0.05) or L-arginine (36.2±0.050С, 
P0.001).  
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Figure 1: Rectal temperature in rat after the hypothermia and  rewarming combined with a modification of L-arginine-
NO pathway: 
1 – hypothermia/rewarming; 2 - SNP + hypothermia/rewarming; 3 - L-NAME + hypothermia/rewarming; 4 –  L-arginine 
+ hypothermia/rewarming. * - significant difference from hypothermia/rewarming group. 
 
Table 1 presents the data for the changes of blood oxygen transport indices. In hypothermic rats the significant lowering 
of PO2 occured (12.9%, P<0.001), and SO2 increased на 12.3% (P<0.01). Administration of L-arginine resulted into 
significant increase of PO2 and decrease of SO2 comparing with group 2 (by 14.4%, P<0.01 and 10.9%, P<0.001, 
respectively). Injection of SNP or L-NAME did not cause any detectable PO2 changes, but significantly decreased 
oxygen saturation of hemoglobin comparing with group 2 (by 18.8%, P<0.001, and 20.4%, P<0.001, respectively). 
Administration of SNP decreased PO2 by 7.4%, P<0.01, and SO2 by 6.2%, P<0.05, and also injection of L-NAME 
decreased PO2 by 8.5%, P<0.01 comparing with group of hypothermia and rewarming. Rats of group 2 had the 
significantly lower pH (7.238±0.01 vs. 7.351±0.01 in control, P<0.001).  
In rats subjected to cold only, P50stand rose by 7.1% (P<0.01), and P50act fell by 15.4% (P<0.001) from baseline. 
Cooling with the following rewarming increased P50stand by 4.4% (P<0.05) and P50act by 22.4% (P<0.001) vs. group 
of hypothermia. L-NAME during the hypothermia and the following rewarming decreased P50act by 7.9% (P<0.01), 
thereby shifting ODC leftwards (Figure 2), and P50stand - by 10.6% (P<0.001) vs. group 3. Injection of L-arginine 
during the hypothermia with the following rewarming resulted in the higher P50act (by 8.1%, P<0.01) and ODC shift 
rightwards (Figure 2), without the changes in P50stand comparing with group 3. SNP did not affect the P50 comparing 
with group 3. 
Table 1: Blood oxygen transport indices in rats under hypothermia and after rewarming combined with a modification of 
L-arginine-NO pathway (MSEM) 
Parameter Control Hypothermia 
Hypothermia 
/rewarming 
SNP + 
hypothermia 
/rewarming 
L-NAME  + 
hypothermia 
/rewarming 
L-arginine + 
hypothermia  
/rewarming 
N 8 8 11 9 10 8 
P50stand, mm Hg 30.93±0.42 33.13±0.47 * 31.66±0.54 # 31.38±0.47 # 28.31±0.46 * #  33.13±0.58 * 
P50act, mm Hg 29.20±0.49 24.70±0.37 * 30.23±0.40 # 30.84±0.47 * # 27.84±0.40  #  32.69±0.29* #  
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Hb, g/L 106.3±2.66 113.4±6.19 106±3.39 107.9±2.67 118.2±3.83 *  119.9±3.83 *  
PO2, mm Hg 28.00±0.42 24,38±0,50 * 27.00±0.47 # 25.00±0.29 *   24.70±0.40 *  27.88±0.52 # 
PO2act, mm Hg 24.76±0.85 13.19±0.19* 24.03±0.50 # 22.8±0.35 * # 21.71±0.28 * #  26.23±0.50 #  
PCO2, mm Hg 54.31±0.68 56.51±0.86 50.45±0.87 *  # 51.22±0.54 * # 51.73±0.91* # 51.73±1.10 # 
PCO2act, mm Hg 50.09±0.97 38.14±0.83 * 47.02±0.60 *  # 48.26±0.66 # 47.62±0.92 # 49.74±1.02 #  
SO2, % 28.80±0.45 32.34±0.81 * 27.99±0.38 # 26.27±0.47 *#  25.76±0.94* # 28.83±0.19 # 
metHb, % 0.11±0.06 0.14±0.07 0.06±0.03 0.11±0.07 0.05±0.02 0.11±0.05 
pH, units 7.351±0.01 7.238±0.01 * 7.347±0.002 # 7.348±0.01 # 7.324±0.01 #  7.358±0.01 # 
pHact, units 7.378±0.01 7.361±0.01 7.37±0.003 7.367±0.01 7.351±0.01 7.37±0.01 
HCO3
-, mM 31.35±0.89 28.98±0.66 30.18±0.92 28.64±0.56 * 28.18±0.86 * 31.20±0.99 
TCO2, mM 32.94±0.94 31.40±0.72 31.72±0.98 30.27±0.62 * 29.88±0.95 * 32.30±0.94 
ABE, mM 4.78±0.63 0.07±1.13 * 4.79±0.68 # 2.92±0.38 *  1.70±0.53 *  5.61±0.43 # 
SBE, mM 5.18±0.76 0.23±1.35 * 4.85±0.85 # 2.80±0.45 * 1.74±0.70*  5.55±0.97 # 
SBC, mM 27.25±0.49 24.10±0.71 * 26.95±0.65 # 25.84±0.30 * # 24.80±0.40 *  27.48±0.54 # 
 
Abbreviations used: P50stand, blood PO2 under its 50% saturation by O2  as determined at 37°C, pH 7.4 and PCO2 = 40 
mm Hg; P50act,  P50 at actual pH, PCO2 and temperature; Hb, hemoglobin; PO2, venous oxygen pressure; PCO2, venous 
carbon dioxide pressure; SO2, O2 blood saturation; metHb, methemoglobin;  HCO3
-, plasma concentration of 
hydrocarbonates; TСО2 , concentration of total carbon dioxide; ABE,  the actual excess of buffer bases; SBE standard 
excess of buffer bases; SBC, standard hydrocarbonate. 
* - Significant difference from control group; 
# - Significant difference from hypothermic group; 
 - Significant difference from hypothermia/rewarming group. 
 
 
Figure 2: Actual oxyhemoglobin dissociation curves in rats of the following groups: 
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Control (), hypothermia/rewarming (), L-arginine + hypothermia/rewarming (), L-NAME + 
hypothermia/rewarming (). 
 
Hypothermia increased the nitrate/nitrite content by 34.7±0.43% (P<0.001) vs. control (Fig. 3). The rewarming only 
partially restored it (9.8±0.37%, P<0.05 vs. control). SNP and L-arginine rose the nitrate/nitrite level by 31.1±0.54% 
(P<0.001) and 10.9±0.35% (P<0.05), respectively, comparing with a group 3, whereas the injection of L-NAME 
decreased it by 21.7±0.22% (P<0.001)  (Fig. 3). 
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Figure 3: The content of nitrate/nitrite in plasma of rats after the hypothermia and  rewarming combined with a 
modification of L-arginine-NO pathway: 
1 - control; 2 - hypothermia; 3 – hypothermia/rewarming; 4 - SNP + hypothermia/rewarming; 5 - L-NAME + 
hypothermia/rewarming; 6 –  L-arginine + hypothermia/rewarming. * - significant difference from control group; # - 
significant difference from hypothermic group;   - significant difference from hypothermia/rewarming group. 
 
Table 2 shows the LPO parameters.  Hypothermia increased CD content comparing with control in all the tissues 
studied: in lungs by 46% (P<0.001), in liver by 34% (P<0.01), in kidneys by 33% (P<0.001), and in myocardium by 41% 
(P<0.001). CD content in group 3 also was higher than in control: by 42% in lungs (P<0.001), by 26% in liver (P<0.01), 
by 27% in kidneys (P<0.01), and by 32% in myocardium (P<0.001). In group 2 SB content rose comparing with control: 
by 18% in lungs (P<0.001), by 25% in liver (P<0.001), by 29% in kidneys (P<0.001), and by 24% in myocardium 
(P<0.001). Group of hypothermia and rewarming displayed the similar SB increase vs. control: by 16% in lungs 
(P<0.001), by 29% in liver (P<0.001), by 21% in kidneys (P<0.001), and by 22% in myocardium (P<0.001). L-arginine 
administration during the hypothermia resulted in the lower CD content during the rewarming in all the tissues studied: in 
lungs by 20% (P<0.01), in liver by 14% (P<0.01), in kidneys by 10% (P<0.05), and in myocardium by 14% (P<0.01); SB 
content also fell comparing with group 3: by 8% in lungs (P<0.01), by 19% in liver (P<0.001), by 10% in kidneys 
(P<0.01), and by 17% in myocardium (P<0.001). SNP or L-NAME did not change the LPO activity after the 
hypothermia and rewarming. 
 
Table 2: Lipid peroxidation indices in rat blood and tissues under hypothermia and rewarming  combined with modified 
L-arginine-NO pathway (MSEM) 
 
Parameter 
Control Hypothermia 
Hypothermia 
/rewarming 
SNP + 
hypothermia 
/rewarming 
L-NAME + 
hypothermia 
/rewarming 
L-arginine + 
hypothermia 
/rewarming 
 
 
CD, 

Lungs 7,35±0,24 10,73±0,34 * 10,41±0,39 * 10,36±0,91 * 10,96±0,31 * 8,34±0,42 # Ψ 
Liver 9,23±0,48 12,34±0,65 * 11,59±0,32 * 12,94±0,42 *Ψ 14,97±0,47 *#Ψ 10,01±0,34 #Ψ Ре
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A233/g Kidneys 7,85±0,36 10,41±0,27 * 9,98±0,32 *  12,08±0,38 *#Ψ 10,09±0,43 * 8,96±0,25 #Ψ 
Heart 7,86±0,38 11,09±0,37 * 10,35±0,27 * 10,99±0,37 * 10,96±0,46 * 8,88±0,33 #Ψ 
 
 
SB, 
units/g 
Lungs 213,8±2,57 252,7±2,73 * 248,5±3,81 * 244,4±2,62 * 252,1±3,03 * 228,1±1,76 *#Ψ 
Liver 199,7±3,08 249,0±2,61 * 257,4±2,87 * 264,9±3,11 *# 262,7±3,19 *# 208,1±2,17 #Ψ 
Kidneys 114,1±2,69 146,9±2,06 * 137,8±2,57 *# 149,3±2,54 *Ψ 135,6±2,80 *# 124,3±2,54 *#Ψ 
Heart 208,6±2,42 259,3±2,10 * 248,3±2,54 *# 245,9±2,87 *# 245,1±3,61 *# 205,8±2,87 #Ψ 
Abbreviation used: CD - conjugated diene content; SB - Schiff base content.  
* - Significant difference from control group; 
# - Significant difference from hypothermic group; 
  - Significant difference from hypothermia/rewarming group. 
 
Hypothermia resulted in lower catalase activity (Figure 4A): by 25% in liver (P<0.001), by 19% in kidneys (P<0.01), 
and by 27% in myocardium (P<0.05). Rewarming also decreased the catalase activity vs. control: by 19% in liver 
(P<0.001), and by 12% in kidneys (P<0.05). SNP injection increased its activity comparing with group 3: by 49% in 
lungs (P<0.05), and by 13% in liver (P<0.05). L-arginine rose it in liver by 18% (P<0.001); by 11% in kidneys (P<0.05), 
and in myocardium by 47% (P<0.05). However L-NAME did not affect this enzymatic activity comparing with a group 
3. 
During the hypothermia α-T contents were lower than control in all the tissues studied (Figure 4B): in lungs by 26% 
(P<0.001), in liver by 17% (P<0.001), in kidneys by 13% (P<0.001), and in myocardium by 16% (P<0.001). Similar α-T 
decrease was observed in a group of hypothermia and rewarming: by 17% in lungs (P<0.001), by 16% in liver (P<0.001), 
by 11% in kidneys (P<0.001), and by 17% in myocardium (P<0.001). L-arginine increased α-T content during the 
rewarming comparing with group 3: by 13% in lungs (P<0.001), by 32% in liver (P<0.001), by 24% in kidneys 
(P<0.001), and by 16% in myocardium (P<0.001). SNP or L-NAME enhanced this content relatively to group 3 in liver, 
kidneys and myocardium. 
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Figure 4: Changes in antioxidant defense indices (A - catalase activity, and B - -tocopherol content) in rat tissues during 
hypothermia and rewarming combined with the modified  L-arginine-NO pathway: 
1 -  control; 2 -  hypothermia; 3 -  hypothermia/rewarming; 4 - SNP + hypothermia/rewarming; 5 - L-NAME + 
hypothermia/rewarming; 6 –  L-arginine + hypothermia/rewarming. * - significant difference from control group; # - 
significant difference from hypothermic group;   - significant difference from hypothermia/rewarming group. 
 
4. DISCUSSION 
L-arginine resulted in the slower rectal temperature fall in rats during the cold exposure and its faster return to baseline 
during the rewarming. However, other modifiers of L-arginine-NO pathway (SNP, L-NAME) had not such effect, 
revealing the complex nature of NO system contribution into the temperature homeostasis. NO may affect the 
temperature homeostasis by directly, modulating the thermoregulatory mechanisms 25, or indirectly, through its influence 
on the blood oxygen transport and prooxidant-antioxidant balance 28. The pattern of changes in PО2 and acid-base 
parameters during the hypothermia reflects the development of metabolic acidosis and hypoxia, most weak in animals 
received L-arginine only. Lower temperature shifts ODC leftwards resulting in the reduction of oxygen flux to tissues 29. 
The higher CD and SB and lower α-T levels in tissue homogenates indicated the prooxidant-antioxidant disbalance both 
after the cooling and after the rewarming. Acute cold exposure of homoiothermic body resulted in LPO activation in 
various organs and tissues 3. Rewarming did not restore the prooxidant-antioxidant balance revealing an in 
compensability of its changes, at least, in a period of 2 hrs. L-arginine reduced the prooxidant-antioxidant disbalance. 
Our previous experiments indicated the various changes of the blood oxygen transport indices in rats receiving the 
various L-arginine-NO pathway modifiers. For example, L-arginine resulted in enhanced cold resistance, milder oxygen 
deficiency and weaker ODC shift, whereas SNP had not the protective effect 28. The present results showed the similar 
difference in modifier effect also during the rewarming.  In our experiments, L-arginine displayed the antioxidant 
properties. NO is an endogenous free radical scavenger; its presence markedly reduced the cytotoxicity of O2
- or H2O2 
7. 
The observed rise of -tocopherol content in rats treated by L-arginine also would facilitate the free radical utilization 
and changed the activities of antioxidant enzymes through its membrane-stabilizing effect and limiting of reactive 
oxygen species permeation into the internal hydrophobic membrane part. 
The changes in L-arginine-NO pathway activity on the whole affect the blood oxygen transport indices 19. NO is made 
possible through an allosterically controlled nitrite reductase reaction with the heme moiety of Hb 12. Hb is capable of 
fulfilling the function of NO storage in the microcirculatory network. In the vascular network, the nitrosothiols produced 
in NO-mediated thiol nitrosylation play an important role in NO transport, storage and metabolism 9. RBCs express a 
functional endothelial NO synthase. An endothelial isoform nitric oxide synthase-like protein and activity in RBCs  
serving regulatory functions in RBCs and platelets 13.The effect of SNO-Hb population on NO supply to tissues can be 
very pronounced since the mechanism of its release from this Hb compound is very sensitive to deoxygenation and is 
especially manifested in considerable PO2 changing (in hypoxic area) 
16.  The dependence of NO on the allosteric state of 
Hb suggests that the NO-donor activity of SNO-Hb may anchance the O2 delivery properties of blood in a fashion 
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dependent on local hypoxia 17. The rate at which NO dissociates from Hb is cooperative so that, similar to the case of O2, 
the cooperativity in equilibrium ligand binding is manifested in the dissociation rate rather than the association rate 11. 
Recent studies reveal a novel role for Hb as an allosterically regulated nitrite reductase that may mediate NO-dependent 
signaling along the physiological oxygen gradient 6. NO can be the allosteric effector of Hb, increasing or decreasing its 
HOA – possibly, through the generation of different NO-Hb derivatives. 27. The importance of NO binding with Hb 
hemes is not only in its immediate effect on the functional behavior of NO-carrying molecules, but also on the Hb 
population at this site of the vascular system. As for microcirculation, this can be extremely important for modifying NO 
oxygen-binding properties and, in the long run, for tissue oxygenation 30. HOA  decrease is favorable during the deep 
hypothermia due to the optimized oxygen flux to tissues and its lower fraction spent for the free radical reactions that is 
associated with the less marked distresses of prooxidant-antioxidant balance 29.  
The present data showed that L-arginine administration improved the oxygen transport – probably, through Hb 
interaction with NO. Infusion of L-arginine promoted the higher cold resistance and ODC shift rightwards, thereby 
reducing the hypoxic signs. In addition, it enhanced the antioxidant defense and reduced the levels of LPO products, 
thereby providing the least prooxidant-antioxidant disbalance during the rewarming.  
5. CONCLUSION 
The L-arginine effect mediated by hemoglobin-oxygen affinity change may be used for the correction of metabolic 
disorders and improvement of body resistance to low environmental temperature. 
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